![]() |
市場調查報告書
商品編碼
1383495
2030 年醫療設備市場預測:按產品類型、應用、最終用戶和地區分類的全球分析Medical Device Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球醫療設備市場規模將達5,526億美元,預計2030年將達到9,410億美元,預測期內年複合成長率為7.9%。
設計用於識別、減輕、監測、治療或預防疾病或損傷的儀器、機器、植入和體外試劑稱為醫療設備。醫療設備具有廣泛的用途和複雜程度,但它們對醫療保健至關重要,因為它們有助於診斷和治療疾病。製造商、零售商和法規機構都在醫療設備領域開展國際業務,這是一項全球性業務。
根據 IDF 發布的 2022 年統計數據,2021 年加拿大約有 290 萬人患有糖尿病。此外,根據同一消息來源,預計這一數字到 2030 年將達到 320 萬,到 2045 年將達到 340 萬。
醫療設備市場受到慢性病發病率上升的嚴重影響。慢性病通常需要持續的照護和監測,例如糖尿病、呼吸系統疾病、心血管疾病和一些癌症。此外,持續監測的需求導致了遠端患者監測技術的技術進步。因此,醫療保健提供者可以透過具有藍牙和網路存取等連接特性的醫療設備遠端監控患者。
昂貴的醫療設備可能會對醫療保健財政造成壓力,尤其是在公共資助的系統中。此外,對於醫院和其他醫療機構來說,購買和維護先進技術的成本過高,並影響整體營運預算。這使得門診和農村診所等小型醫療機構難以購買昂貴的醫療設備並提供廣泛的服務,導致醫療服務提供有限,這可能會造成差距並阻礙市場成長。
對血糖儀、穿戴式健身追蹤器和血壓計等家庭監測設備的需求正在迅速成長,這些小工具使人們無需經常去醫療機構即可掌握自己的健康問題,並且可以進行管理。因此,由於家庭醫療設備的需求,科技正在不斷發展。為了改善患者的整體體驗,製造商正在開發具有直覺使用者介面、連接性和遠端監控功能的設備。家用數位體溫計和遠端醫療平台是實現遠距醫療諮詢、推動市場成長的設備的主要範例。
法規調整預計將增加提供患者服務和開發新產品的成本。這些與消費者保密相關的進步包括歐盟 (EU) 實施《一般資料保護規範》(GDPR) 和對設備核准的修訂。美國FDA正在尋求更多的臨床證據來支持內視鏡工具等醫療設備的安全性和有效性主張,導致過去年度來完成上市核准流程所需的時間有所延長。由於設備發布延遲而造成的收益損失以及嚴格的法規流程可能導致的成本增加將影響對創新設備的投資並影響醫療設備市場的成長。
COVID-19大流行對全球醫療設備市場產生了各種影響。世界各地冠狀病毒診斷的意外增加增加了對醫療設備的需求,包括呼吸設備、人工呼吸器、口罩、個人防護設備包等。此外,在 COVID-19 爆發期間,遠端醫療和遠端患者監護等數位醫療技術的使用急劇增加。醫療設備市場目前正以更快的速度擴張。然而,在 COVID-19 疫情高峰期,所有非必要手術都被擱置,優先考慮擇期手術治療。這對製造必要外科手術醫療設備的公司產生了負面影響。
由於心血管疾病盛行率的增加、知名行業參與者的戰術性舉措以及心臟病設備的技術進步等多種原因,預計心臟病設備行業將出現良好的成長。此外,患有肥胖、糖尿病、高血壓和高膽固醇的人往往壽命更長,並且更有可能出現心臟問題,因此這些條件也推動了對心臟醫療設備的需求。此外,由於業務擴張和技術進步(例如在心臟穿戴裝置中使用人工智慧),越來越多的患者正在使用心臟病設備進行管理,治療和監測結果正在顯著改善,正在推動市場成長。
由於醫療保健專業人員在診斷中心進行測試和治療以診斷、追蹤和治療疾病,因此診斷中心細分市場預計將在預測期內出現最高的年複合成長率年成長率。診斷設施中使用的醫療設備有多種用途。診斷中心採用最先進的醫療設備,以提高診斷的準確性、速度和效率。此外,它還支持疾病的早期診斷、追蹤和客製化治療計劃。診斷中心提供優質醫療保健服務的能力不斷受到快速變化的診斷技術領域的影響。
預計北美在預測期內將佔據最大的市場佔有率。在預測期內,由於慢性病盛行率上升、醫療成本高昂以及領先公司的存在等因素,預計北美將引領醫療設備市場。此外,由於普通人群中急性呼吸症候群等呼吸系統疾病和心血管心臟疾病和中風等慢性疾病的患病率不斷上升,心肺體外迴圈手術的增加,對醫療設備的需求也在增加。 。 因此,隨著企業專注於創造尖端產品,並採取聯盟、收購等多樣化的商業策略來維持自己的市場地位,市場正在不斷擴大,這就是我開始做的結果。
由於人口高齡化、人均收入增加和人們健康意識增強等因素,亞太地區在預測期內成長最快。此外,該地區醫療基礎設施投資的增加預計也將促進醫療設備市場的成長。中國和印度是亞太地區的主要國家,以銷售額計算,分別位居全球市場第二和第五名。在這些國家,醫療改革和地方政府的獎勵在很大程度上控制著醫療設備產業。
According to Stratistics MRC, the Global Medical Device Market is accounted for $552.6 billion in 2023 and is expected to reach $941.0 billion by 2030 growing at a CAGR of 7.9% during the forecast period. An equipment, machine, implant, or in vitro reagent designed to be used in the identification, mitigation, monitoring, treatment, or prevention of illness or damage is referred to as a medical device. Medical devices come in a wide range of applications and levels of sophistication, but they are all vital to healthcare since they help with diagnosis and treatment of medical disorders. Manufacturers, retailers, and regulatory agencies all operate internationally in the medical device sector, which is a worldwide business.
According to 2022 statistics published by IDF, about 2.9 million people were living with diabetes in Canada in 2021. In addition, as per the same source, this number is projected to reach 3.2 million and 3.4 million by 2030 and 2045, respectively.
The market for medical devices is significantly impacted by the growing incidence of chronic illnesses. Chronic illnesses frequently call for ongoing care and observation, including diabetes, respiratory conditions, cardiovascular diseases, and some forms of cancer. Additionally, remote patient monitoring technologies have advanced technologically due to the requirement for constant monitoring. Thus, healthcare providers can remotely monitor patients to medical gadgets that include connection characteristics like Bluetooth and internet access.
Expensive medical equipment may put a strain on healthcare finances, especially in systems that receive public funding. Moreover, the cost of purchasing and maintaining sophisticated technology can be prohibitive for hospitals and other healthcare institutions, which has an impact on their entire operating budget. Thus expensive medical equipment may be difficult for smaller healthcare institutions, such outpatient clinics or rural clinics, to afford and this makes it more difficult for them to offer a wide range of services, which might result in gaps in the delivery of healthcare thereby hampering the market growth
There has been a surge in demand for home monitoring equipment, including glucometers, wearable fitness trackers, and blood pressure monitors and with the use of these gadgets, people may keep tabs on and take control of their health issues without constantly visiting medical institutions. Thus technology is always evolving due to the need for at-home medical equipment. To improve the entire patient experience, manufacturers are creating devices with intuitive user interfaces, connection features, and remote monitoring capabilities. Digital thermometers for use at home and telehealth platforms have become popular examples of devices that make remote consultations possible thereby propelling the growth of the market.
Regulatory adjustments are expected to lead to higher costs for patient service offerings and the creation of new products. Among these advances related to secrecy of consumption are the General Data Protection Regulation (GDPR), which was put into effect by the European Union, and modifications to device approvals. The US FDA has asked for more clinical evidence to support the security and efficacy claims of medical equipment, such as endoscopic tools, which has resulted in a decreased extension of the time required to complete the marketing authorization process during the last ten years. The potential for missed revenues due to device release delays and higher costs as a result of onerous regulatory processes put pressure on investments in innovative devices, which affect the growth of the market for medical devices.
The COVID-19 pandemic affected the world market for medical equipment in a variety of ways. The unexpected increase in corona virus diagnoses around the globe has increased demand for medical equipment including respiration devices, ventilators, masks, personal protective equipment kits, and other items. Additionally, the use of digital health technologies like telemedicine and remote patient monitoring has increased dramatically during the COVID-19 epidemic. The market for medical equipment is expanding at a faster rate now. However, all non-essential surgical operations were put on hold during the peak days of COVID-19, giving preference to elective surgical treatments. This had a detrimental impact on the firms who make medical devices for necessary surgical procedures.
The cardiology devices segment is estimated to have a lucrative growth, due to many reasons, including the increasing incidence of cardiovascular illnesses, tactical moves by prominent industry players, and advancements in technology in cardiology devices. Furthermore, since more people with obesity, diabetes, hypertension, and high cholesterol live longer lives and are more prone to experience cardiac issues, these conditions are also driving up demand for cardiological medical equipment. Furthermore, an increasing number of patients are being managed with cardiology devices as a result of expanding business operations and technological advancements (such as the use of artificial intelligence in cardiac wearable devices), which has led to exponential therapeutical and monitoring outcomes are driving the growth of the market.
The diagnostic centers segment is anticipated to witness the highest CAGR growth during the forecast period, as healthcare experts conduct tests and treatments in diagnostic centers in order to diagnose, track, and treat illnesses. Diagnostic facilities employ medical equipment for a variety of purposes. Diagnostic accuracy, speed, and efficiency are all improved in diagnostic centers by the incorporation of cutting-edge medical equipment. Additionally, it supports the early diagnosis, tracking, and customized treatment planning of diseases. Diagnostic centers' capacity to deliver high-quality healthcare services is continually shaped by the rapidly changing field of diagnostic technologies.
North America is projected to hold the largest market share during the forecast period owing to the Over the course of the forecast period, North America is anticipated to lead the medical devices market due to factors including the rising prevalence of chronic illnesses, high healthcare costs, and the presence of major companies. Furthermore, the medical device demand rises as a result of an increase in cardiopulmonary bypass procedures brought on by the rising prevalence of respiratory diseases like acute respiratory syndrome and chronic diseases like cardiovascular disease, coronary heart disease, and stroke in the general population. Thus the market is expanding as a result of businesses' increasing emphasis on creating cutting-edge goods and their adoption of diverse business tactics, such partnerships and acquisitions, to maintain their market positions.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to factors such as an aging population, rising per capita income, and increased health consciousness among the populace, the Asia Pacific area grew at the quickest rate throughout the projected period. Moreover, the rising investments in the region's healthcare infrastructure are expected to support the growth of the medical device market. China and India are two of the major nations in the Asia Pacific area, ranking second and fifth respectively in the world market for revenue. In these nations, healthcare reforms and incentives provided by local governments mostly control the medical device industry.
Some of the key players profiled in the Medical Device Market include: Stryker, Medtronic, Fresenius SE & Co. KGaA, Abbott, Cardinal Health, BD, Koninklijke Philips N.V., General Electric Company, Siemens Healthineers AG, 3M Company, Boston Scientific Corporation, F. Hoffmann-La Roche Ltd, Smith & Nephew PLC, Braun Melsungen AG, Intuitive Surgical, Fujifilm, Canon Medical Systems, Alcon Laboratories, Edwards Lifesciences and Thermo Fisher
In November 2023, Fresenius Kabi announced the launch of its tocilizumab biosimilar Tyenne® referencing RoActemra®** (tocilizumab) in the European Union. Tyenne® becomes the first tocilizumab biosimilar available in Europe for the treatment of several inflammatory and immune diseases.
In September 2023, Medtronic plc in healthcare technology, announced CE (Conformite Europeenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.